[HTML][HTML] Alteration of laboratory findings after radiofrequency ablation of hepatocellular carcinoma: relationship to severity of the underlying liver disease and the …
SW Shin, WK Jeong, S Lim, Y Kim… - Clinical and Molecular …, 2015 - ncbi.nlm.nih.gov
Methods This retrospective analysis included 65 patients (44 males, 21 females) who
underwent RFA of HCC. Hematologic and biochemical markers were assessed at the pre …
underwent RFA of HCC. Hematologic and biochemical markers were assessed at the pre …
Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes
H Nishikawa, Y Osaki, E Iguchi, H Takeda… - Journal of …, 2013 - Springer
Background In our previous study, we classified the radicality (R grading) of percutaneous
radiofrequency ablation (RFA) therapy for single hepatocellular carcinoma (HCC) according …
radiofrequency ablation (RFA) therapy for single hepatocellular carcinoma (HCC) according …
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: usefulness of albumin–bilirubin grade
A Hiraoka, T Kumada, M Hirooka, K Tsuji… - Hepatology …, 2018 - Wiley Online Library
Aim To evaluate the efficacy of the newly proposed albumin–bilirubin (ALBI) grade for
therapy selection, clinical features of patients treated with radiofrequency ablation (RFA) …
therapy selection, clinical features of patients treated with radiofrequency ablation (RFA) …
Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma
J Imamura, R Tateishi, S Shiina, E Goto… - Official journal of the …, 2008 - journals.lww.com
BACKGROUND Neoplastic seeding reportedly occurs in up to 12.5% of patients treated with
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The aim of this study is …
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The aim of this study is …
The influence on liver parenchymal function and complications of radiofrequency ablation or the combination with transcatheter arterial embolization for hepatocellular …
M Koda, M Ueki, Y Maeda, KI Mimura, K Okamoto… - Hepatology …, 2004 - Elsevier
Objectives: We investigated how radiofrequency ablation (RFA) alone or the combination
with transcatheter arterial embolization (TAE–RFA) for hepatocellular carcinoma (HCC) …
with transcatheter arterial embolization (TAE–RFA) for hepatocellular carcinoma (HCC) …
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase–platelet …
WY Kao, YY Chiou, HH Hung, YH Chou… - European journal of …, 2011 - journals.lww.com
Objective Percutaneous radiofrequency ablation (RFA) is one of the first-line curative
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …
therapies for hepatocellular carcinoma (HCC), but factors affecting the prognosis remain …
Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma.
C Ogawa, M Kudo, Y Minami, H Chung… - Hepato …, 2008 - europepmc.org
Results Multivariate analysis revealed that of the three tumor makers only AFP-L3 showed
significant differences in the survival and disease-free rates. Conclusions AFP-L3 is the most …
significant differences in the survival and disease-free rates. Conclusions AFP-L3 is the most …
Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor …
H Nishikawa, T Inuzuka, H Takeda, J Nakajima… - Journal of …, 2011 - Springer
Background In the present study we classified the radicality of percutaneous radiofrequency
thermal ablation (RFA) therapy according to the extent of the ablated margin. We measured …
thermal ablation (RFA) therapy according to the extent of the ablated margin. We measured …
Pitfalls in the radiological and pathological correlation of tumour response rates of hepatocellular carcinoma following radiofrequency ablation
YK Cho, Y Kim, H Rhim - Journal of clinical pathology, 2009 - jcp.bmj.com
According to the American Association for the Study of Liver Diseases (AASLD) guidelines,
radiofrequency ablation (RFA) is a safe and effective treatment for patients with unresectable …
radiofrequency ablation (RFA) is a safe and effective treatment for patients with unresectable …
Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma
H Kuroda, K Kasai, K Kakisaka, Y Yasumi… - Hepatology …, 2010 - Wiley Online Library
Aim: To evaluate changes in liver function parameters and risk factors 1 year after
percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular …
percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular …